Basic Information
MCSMED is committed to building an integrated platform from pre-hospital emergency care to clinical support. With the core strategy of "Intervention + Emergency + Service," the company has independently developed several medical devices with breakthrough performance. It has currently deployed core products such as the PulseVAD® Interventional Ventricular Assist System, Mcsreboa® Resuscitative Aortic Occlusion Balloon, and Smartpress™ Intelligent CPR Compression Device. These core products have clear clinical positioning and proprietary patent technologies, along with well-defined regulatory approval plans and market strategies.
--
Zhejiang,China
15~50 people
March 27, 2024
--
wengyan@mcsmed.cn

